This is excellent coverage given the global readership of Neuronews, as follows:
"NeuroNews is a medical publication providing the latest news from the neurovascular and neuromodulation fields. Our target audience consists of neurointerventionists and interventional neuroradiologists, as well as neurosurgeons, neurologists, stroke physicians and pain management specialists. Through our print newspaper, website and social media channels, we deliver breaking news, exclusive interviews, conference coverage and original content on everything from stroke care and intracranial aneurysm treatments, to carotid artery disease and brain stimulation".
EMV Price at posting:
$1.89 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)